243 related articles for article (PubMed ID: 29947629)
21. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
Andréola ML
Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
[TBL] [Abstract][Full Text] [Related]
22. Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations.
Fikkert V; Van Maele B; Vercammen J; Hantson A; Van Remoortel B; Michiels M; Gurnari C; Pannecouque C; De Maeyer M; Engelborghs Y; De Clercq E; Debyser Z; Witvrouw M
J Virol; 2003 Nov; 77(21):11459-70. PubMed ID: 14557631
[TBL] [Abstract][Full Text] [Related]
23. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
25. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds].
Yu SH; Tan YM; Zhao GS
Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431
[TBL] [Abstract][Full Text] [Related]
26. [Computer search for novel HIV-1 integrase inhibitors].
Akimov DV; Filimonov DA; Prikazchikova TA; Gottikh MB; Poroĭkov VV
Biomed Khim; 2005; 51(3):335-40. PubMed ID: 16104397
[TBL] [Abstract][Full Text] [Related]
27. Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor.
Brigo A; Lee KW; Fogolari F; Mustata GI; Briggs JM
Proteins; 2005 Jun; 59(4):723-41. PubMed ID: 15815973
[TBL] [Abstract][Full Text] [Related]
28. Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Di Santo R; Costi R; Roux A; Artico M; Lavecchia A; Marinelli L; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2006 Mar; 49(6):1939-45. PubMed ID: 16539381
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H.
Yang F; Yang J; Zhang Z; Tu G; Yao X; Xue W; Zhu F
Curr Med Chem; 2022; 29(10):1664-1676. PubMed ID: 34238145
[TBL] [Abstract][Full Text] [Related]
30. Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity.
Vernekar SKV; Tang J; Wu B; Huber AD; Casey MC; Myshakina N; Wilson DJ; Kankanala J; Kirby KA; Parniak MA; Sarafianos SG; Wang Z
J Med Chem; 2017 Jun; 60(12):5045-5056. PubMed ID: 28525279
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors.
Carcelli M; Rogolino D; Sechi M; Rispoli G; Fisicaro E; Compari C; Grandi N; Corona A; Tramontano E; Pannecouque C; Naesens L
Eur J Med Chem; 2014 Aug; 83():594-600. PubMed ID: 24996145
[TBL] [Abstract][Full Text] [Related]
32. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
[TBL] [Abstract][Full Text] [Related]
33. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase.
Li X; Vince R
Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908
[TBL] [Abstract][Full Text] [Related]
34. Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges.
Wang X; Gao P; Menendez-Arias L; Liu X; Zhan P
Curr Med Chem; 2018; 25(14):1682-1702. PubMed ID: 28088905
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
[TBL] [Abstract][Full Text] [Related]
36. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
Dayam R; Sanchez T; Neamati N
J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
[TBL] [Abstract][Full Text] [Related]
37. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
[TBL] [Abstract][Full Text] [Related]
38. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
[TBL] [Abstract][Full Text] [Related]
39. Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.
Barreca ML; Iraci N; De Luca L; Chimirri A
ChemMedChem; 2009 Sep; 4(9):1446-56. PubMed ID: 19544345
[TBL] [Abstract][Full Text] [Related]
40. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
Gupta P; Kumar R; Garg P; Singh IP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
